4//SEC Filing
Plano Matthew T. 4
Accession 0001415889-22-011065
CIK 0000815094other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:52 PM ET
Size
23.4 KB
Accession
0001415889-22-011065
Insider Transaction Report
Form 4
ABIOMED INCNASD
Plano Matthew T.
VP, GLOBAL OPERATIONS
Transactions
- Sale
Common Stock $.01 par value
2022-11-01$377.84/sh−974$368,015→ 12,840 total - Exercise/Conversion
Common Stock $.01 par value
2022-11-01$223.90/sh+1,843$412,648→ 13,814 total - Sale
Common Stock $.01 par value
2022-11-01$378.61/sh−1,699$643,262→ 11,141 total - Sale
Common Stock $.01 par value
2022-11-01$379.33/sh−722$273,877→ 10,419 total - Sale
Common Stock $.01 par value
2022-11-01$380.22/sh−149$56,652→ 10,270 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-01−1,843→ 922 totalExercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Holdings
- 2,000
Stock Option (Right to Buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 2,765
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
Footnotes (8)
- [F1]Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- [F2]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F3]This price represents the sale price of the transactions on the reported date at $377.8389. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F4]This price represents the sale price of the transactions on the reported date at $378.6120. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F5]This price represents the sale price of the transactions on the reported date at $379.3305. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F6]This price represents the sale price of the transactions on the reported date at $380.2151. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F7]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F8]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 2
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001931998
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:52 PM ET
- Size
- 23.4 KB